首页> 外文期刊>Science Advances >Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer
【24h】

Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer

机译:通过BRPF1-KAT6复合物在神经发育障碍和癌症中缺乏组蛋白H3丙酰化

获取原文
获取外文期刊封面目录资料

摘要

Lysine acetyltransferase 6A (KAT6A) and its paralog KAT6B form stoichiometric complexes with bromodomain- and PHD finger-containing protein 1 (BRPF1) for acetylation of histone H3 at lysine 23 (H3K23). We report that these complexes also catalyze H3K23 propionylation in vitro and in vivo. Immunofluorescence microscopy and ATAC-See revealed the association of this modification with active chromatin. Brpf1 deletion obliterates the acylation in mouse embryos and fibroblasts. Moreover, we identify BRPF1 variants in 12 previously unidentified cases of syndromic intellectual disability and demonstrate that these cases and known BRPF1 variants impair H3K23 propionylation. Cardiac anomalies are present in a subset of the cases. H3K23 acylation is also impaired by cancer-derived somatic BRPF1 mutations. Valproate, vorinostat, propionate and butyrate promote H3K23 acylation. These results reveal the dual functionality of BRPF1-KAT6 complexes, shed light on mechanisms underlying related developmental disorders and various cancers, and suggest mutation-based therapy for medical conditions with deficient histone acylation.
机译:赖氨酸乙酰转移酶6a(kat6a)及其寄生虫kat6b与溴琼瓜素和含有溴 - 和含有磷酸的蛋白质1(brpf1)形成化学计量复合物,用于赖氨酸23(H3K23)的组蛋白H3的乙酰化。我们认为这些复合物还在体外和体内催化H3K23丙酰化。免疫荧光显微镜和ATAC看揭示了这种改性与活性染色质的关联。 BRPF1删除删除了小鼠胚胎和成纤维细胞中的酰化。此外,我们鉴定了12例先前未认出的综合征智力残疾病例中BRPF1变体,并证明了这些病例和已知的BRPF1变体损害H3K23丙酰化。心脏异常存在于病例的子集中。 H3K23酰化也受癌症衍生的体细胞BRPF1突变的损害。戊酸酯,vorinostat,丙酸盐和丁酸丁酸促进H3K23酰化。这些结果揭示了BRPF1-KAT6复合物的双重功能,揭示了相关发育障碍的机制和各种癌症的机制,并提出了基于突变的作用治疗缺乏组蛋白酰化的病症。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号